Immunotherapies Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
RCUS | D | Arcus Biosciences, Inc. | 0.06 | |
GOVX | F | GeoVax Labs, Inc. | 0.00 | |
HCWB | F | HCW Biologics Inc. | 0.00 | |
MRKR | F | Marker Therapeutics, Inc. | 1.04 | |
XLO | F | Xilio Therapeutics, Inc. | 0.80 | |
SABS | F | SAB Biotherapeutics, Inc. | -4.13 | |
GRTS | F | Gritstone Oncology, Inc. | 1.14 | |
GDTC | F | CytoMed Therapeutics Limited | 0.38 | |
MURA | F | Mural Oncology plc | 0.00 | |
IMCR | F | Immunocore Holdings plc | -1.29 |
Related Industries: Biotechnology Long-Term Care Facilities Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GERM | C | ETFMG Treatments Testing and Advancements ETF | 2.56 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 2.47 | |
CNCR | D | Loncar Cancer Immunotherapy ETF | 2.19 | |
GURU | A | Global X Top Guru Holdings Index ETF | 1.3 | |
BBP | B | BioShares Biotechnology Products Fund | 1.28 |
Compare ETFs
- Immunotherapies
Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Popular Now
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles